Cigna Corp (CI)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	3,631,000	5,304,000	6,653,000	6,752,000	6,668,000	5,163,000	4,027,000	3,935,000	3,913,000	8,384,000	8,151,000	8,438,000	8,458,000	5,584,000	5,547,000	5,201,000	5,388,000	4,355,000
Total stockholders’ equity	US$ in thousands	46,223,000	45,691,000	45,445,000	44,502,000	44,675,000	45,041,000	45,892,000	46,087,000	47,112,000	47,415,000	48,709,000	48,149,000	50,321,000	48,032,000	47,366,000	45,079,000	45,338,000	44,696,000	43,815,000	42,408,000
ROE		7.86%	11.61%	14.64%	15.17%	14.93%	11.46%	8.77%	8.54%	8.31%	17.68%	16.73%	17.52%	16.81%	11.63%	11.71%	11.54%	11.88%	9.74%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,631,000K ÷ $46,223,000K
= 7.86%

The return on equity (ROE) of Cigna Group (The) has shown fluctuations over the past eight quarters. In Q1 2022, the ROE was 11.69%, which slightly increased to 11.94% in Q2 2022. There was a further increase in Q3 2022 to 14.69% before peaking at 14.86% in Q4 2022. However, the ROE declined in the first two quarters of 2023 to 15.17% in Q1 2023 and 14.64% in Q2 2023. In Q3 2023, there was a slight improvement to 11.61%, followed by 11.17% in Q4 2023.

Overall, the ROE has displayed a mixed performance, with some quarters showing an increase while others have shown a decline. It is essential to further investigate the factors contributing to these fluctuations to determine the sustainability and long-term profitability of Cigna Group (The).